deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT04545307

Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis (MSC)

Transplantation of Allogeneic Mesenchymal Stromal Cells in Patients With Immature Apex Teeth With Pulp Necrosis and Chronic Apical Periodontitis

Sponsor: Instituto Venezolano de Investigaciones Cientificas

Updated 5 times since 2020 Last updated: Sep 14, 2020 Started: Nov 27, 2019 Primary completion: Dec 27, 2019 Completion: Jan 27, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Apical Periodontitis and Pulp Necroses, this trial is completed. The trial is conducted by Instituto Venezolano de Investigaciones Cientificas and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto Venezolano de Investigaciones Cientificas
  • Universidad Central de Venezuela
Data source: Universidad Central de Venezuela

For direct contact, visit the study record on ClinicalTrials.gov .